Search

Your search keyword '"Munshi, S."' showing total 654 results
Start Over Author "Munshi, S."
654 results on '"Munshi, S."'

101. High prevalence of Hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy

Author

Ahmed, M., Munshi, S., Nessa, A., Ullah, M., Tabassum, S., and Islam, M.

Subjects
Flexible response (Strategy), Vaccination, Prevalence studies (Epidemiology), Hepatitis A, Immunoglobulins, Deterrence (Strategy), Hepatitis A virus, Health
Abstract

Serum samples from 465 subjects aged between 1 and 25 years were tested for antibody against hepatitis A virus (HAV) [anti-HAV IgG and IgM] to determine the seroprevalence of HAV [...]

Published
2009

102. HBV, HCV and syphilis co-infections in human immunodeficiency virus positive Bangladeshi patients: Observation at two reference laboratories

Author

Munshi, S., Hoque, M., Mondol, Mea, Jalaluddin, M., Tabassum, S., and Islam, M.

Subjects
HIV (Viruses) -- Care and treatment, HIV (Viruses) -- Health aspects, Syphilis -- Care and treatment, Syphilis -- Health aspects, HIV patients -- Care and treatment, HIV patients -- Health aspects, Hepatitis C -- Care and treatment, Hepatitis C -- Health aspects, Laboratories -- Health aspects, Infection -- Care and treatment, Infection -- Health aspects, Health
Abstract

Dear editor, Human Immunodeficiency Virus (HIV), Hepatitis B virus (HBV), Hepatitis C virus (HCV) and syphilis share certain epidemiological characteristics . In the post highly active antiretroviral therapy (HAART) era, [...]

Published
2008

103. Seroprevalence of rubella among urban and rural Bangladeshi women emphasises the need for rubella vaccination of pre-pubertal girls

Author

Nessa, A., Islam, M., Tabassum, S., Munshi, S., Ahmed, M., and Karim, R.

Subjects
Infection -- Health aspects, Rubella -- Health aspects, Measles-mumps-rubella vaccine -- Health aspects, Women -- Health aspects, Health
Abstract

Dear editor, Rubella virus infection poses a serious threat to the developing foetus if contracted during early pregnancy. In post-rubella vaccination era, endemic rubella and congenital rubella syndrome (CRS) continue [...]

Published
2008

110. Mortality of treated HIV-1 positive individuals according to viral subtype in Europe and Canada

Author

May, MT, Gill, MJ, Wittkop, L, Klein, M, Sabin, C, Harrigan, PR, Dunn, D, Vehreschild, JJ, Rubio, R, Mocroft, A, Cavassini, M, Reiss, P, Monforte, AD, Zangerle, R, Ingle, SM, Hill, T, Jose, S, Sterne, JAC, Boulle, A, Stephan, C, Miro, JM, Chene, G-V, Costagliola, D, Dabis, F, Del Amo, J, Van Sighem, A, Vehreschild, J, Gill, J, Guest, J, Haerry, DH-U, Hogg, R, Justice, A, Obel, N, Crane, H, Smith, C, Saag, M, Sterling, T, Teira, R, Williams, M, Sterne, J, May, M, Ingle, S, Trickey, A, Ainsworth, J, Anderson, J, Babiker, A, Chadwick, D, Delpech, V, Fisher, M, Gazzard, B, Gilson, R, Hay, P, Gompels, M, Johnson, M, Kegg, S, Leen, C, Mackie, N, Nelson, M, Orkin, C, Palfreeman, A, Phillips, A, Pillay, D, Post, F, Sachikonye, M, Schwenk, A, Walsh, J, Thornton, A, Huntington, S, Glabay, A, Garrett, N, Lynch, J, Hand, J, De Souza, C, Perry, N, Tilbury, S, Youssef, E, Churchill, D, Waxman, M, Asboe, D, Mandalia, S, Munshi, S, Awosika, D, Korat, H, Taylor, C, Gleisner, Z, Ibrahim, F, Campbell, L, Baillie, K, Cope, E, Gibney, M, Gibson, J, Brima, N, Williams, I, Miller, S, Wood, C, Youle, M, Lampe, F, Chaloner, C, Winston, A, Weber, J, Ramzan, F, Carder, M, Wilson, A, Morris, S, Allan, S, Moore, A, Fox, L, Bojanowski, J, Lewszuk, A, Main, P, Mitchell, D, Hunter, D, Dhillon, M, Martin, F, Douglas, S, Russell-Sharp, S, Amsterdam institute for Infection and Immunity, Amsterdam Public Health, and Global Health

Subjects
Male, 0301 basic medicine, IMPACT, DIVERSITY, Human immunodeficiency virus (HIV), HIV Infections, medicine.disease_cause, Cohort Studies, 0302 clinical medicine, Immunology and Allergy, Medicine, 030212 general & internal medicine, Cooperative Behavior, Viral failure, Hazard ratio, viral failure, 11 Medical And Health Sciences, Middle Aged, Prognosis, Antiretroviral therapy, 3. Good health, Europe, Infectious Diseases, Anti-Retroviral Agents, INFECTIONS, Cohort, Female, Life Sciences & Biomedicine, NAIVE PATIENTS, Cohort study, Adult, Canada, medicine.medical_specialty, Genotype, Epidemiology and Social, antiretroviral therapy, Immunology, 17 Psychology And Cognitive Sciences, 03 medical and health sciences, Acquired immunodeficiency syndrome (AIDS), Virology, Internal medicine, Humans, TYPE-1 SUBTYPES, Mortality, COMBINATION ANTIRETROVIRAL THERAPY, HIV-1 subtype, Science & Technology, business.industry, DISEASE PROGRESSION, 06 Biological Sciences, medicine.disease, Survival Analysis, mortality, IMMUNOLOGICAL RESPONSE, 030112 virology, Confidence interval, Regimen, HIV-1, prognosis, T-CELL DECLINE, business, RESISTANCE
Abstract

Objectives: To estimate prognosis by viral subtype in HIV-1-infected individuals from start of antiretroviral therapy (ART) and after viral failure.Design: Collaborative analysis of data from eight European and three Canadian cohorts. Methods: Adults (N>20 000) who started triple ART between 1996 and 2012 and had data on viral subtype were followed for mortality. We estimated crude and adjusted (for age, sex, regimen, CD4+ cell count, and AIDS at baseline, period of starting ART, stratified by cohort, region of origin and risk group) mortality hazard ratios (MHR) by subtype. We estimated MHR subsequent to viral failure defined as two HIV-RNA measurements greater than 500 copies/ml after achieving viral suppression.Results: The most prevalent subtypes were B (15 419; 74%), C (2091; 10%), CRF02AG (1057; 5%), A (873; 4%), CRF01AE (506; 2.4%), G (359; 1.7%), and D (232; 1.1%). Subtypes were strongly patterned by region of origin and risk group. During 104 649 person-years of observation, 1172/20 784 patients died. Compared with subtype B, mortality was higher for subtype A, but similar for all other subtypes. MHR for A versus B were 1.13 (95% confidence interval 0.85,1.50) when stratified by cohort, increased to 1.78 (1.27,2.51) on stratification by region and risk, and attenuated to 1.59 (1.14,2.23) on adjustment for covariates. MHR for A versus B was 2.65 (1.64,4.28) and 0.95 (0.57,1.57) for patients who started ART with CD4+ cell count below, or more than, 100 cells/ml, respectively. There was no difference in mortality between subtypes A, B and C after viral failure.Conclusion: Patients with subtype A had worse prognosis, an observation which may be confounded by socio-demographic factors.

Published
2015

114. Persistence of actively acquired and maternally derived antibody in vaccinated goats and their kids against peste des petits ruminants virus

Author

Islam, M. R., Huque, M. E., Munshi, S. U., and Al-Faruque, M. H.

Subjects
Maternal antibody, Health Economics and Policy, Livestock Production/Industries, PPR vaccine, Goat, Humoral antibody
Abstract

To determine the persistence of antibody in goats and maternal antibody in kids after vaccination with peste des petits ruminants (PPR) virus vaccine developed by Bangladesh Livestock Research Institute (BLRI), an experiment was conducted at the Virology Laboratory, Animal Health Research Division, BLRI, Savar, Dhaka. A total of 98 serum samples were collected from 15 PPR vaccinated goats at every six months interval for 4 years. To assess the persistence of maternally derived antibody against PPR virus, blood samples from 5 kids born of PPR vaccinated dams were tested first at 7 days of age, then at every 30 days interval until 150 days of age. All the serum samples were subjected to a competitive enzyme linked immuno sorbent assay (C-ELISA) for the detection of antibody level. Fifty percent inhibition (PI 50%) was considered as the protective antibody level. The protective antibody level in vaccinated goats was found to persist for 4 years.

Published
2007
Full Text
View/download PDF

122. A simplified protocol for differentiation of electrophysiologically mature neuronal networks from human induced pluripotent stem cells

Author

Gunhanlar, N, Shpak, G, van der Kroeg, M, Gouty-Colomer, L A, Munshi, S T, Lendemeijer, B, Ghazvini, M, Dupont, C, Hoogendijk, W J G, Gribnau, J, de Vrij, F M S, and Kushner, S A

Abstract

Progress in elucidating the molecular and cellular pathophysiology of neuropsychiatric disorders has been hindered by the limited availability of living human brain tissue. The emergence of induced pluripotent stem cells (iPSCs) has offered a unique alternative strategy using patient-derived functional neuronal networks. However, methods for reliably generating iPSC-derived neurons with mature electrophysiological characteristics have been difficult to develop. Here, we report a simplified differentiation protocol that yields electrophysiologically mature iPSC-derived cortical lineage neuronal networks without the need for astrocyte co-culture or specialized media. This protocol generates a consistent 60:40 ratio of neurons and astrocytes that arise from a common forebrain neural progenitor. Whole-cell patch-clamp recordings of 114 neurons derived from three independent iPSC lines confirmed their electrophysiological maturity, including resting membrane potential (−58.2±1.0 mV), capacitance (49.1±2.9 pF), action potential (AP) threshold (−50.9±0.5 mV) and AP amplitude (66.5±1.3 mV). Nearly 100% of neurons were capable of firing APs, of which 79% had sustained trains of mature APs with minimal accommodation (peak AP frequency: 11.9±0.5 Hz) and 74% exhibited spontaneous synaptic activity (amplitude, 16.03±0.82 pA; frequency, 1.09±0.17 Hz). We expect this protocol to be of broad applicability for implementing iPSC-based neuronal network models of neuropsychiatric disorders.

Published
2018
Full Text
View/download PDF

125. Introduction

Author

Munshi, S. and Religion, politics and identity in transnational perspectiv (ASSR, FMG)

Published
2001

135. The Parallel Envelope

Author

Rossmann, M.G., Cornea-Hasegan, M. A., Marinsecu, D. C., Zhang, Z., Lynch, Robert E., Muckelbauer, J., McKenna, R., Munshi, S., and Dai, J-B.

Subjects
Computer Sciences
Published
1994

Catalog

Books, media, physical & digital resources
See catalog results